ThreeD Capital Inc. is a publicly-traded Canadian based venture capital firm trading on the Canadian Securities Exchange under the symbol “IDK”.
Our mission is to create unique long-term value to our shareholders by holding a diversified portfolio of early staged investments in disruptive technology, bio-tech and resource companies. ThreeD’s experienced management focuses on opportunistic and early stage investments with high growth potential.
ThreeD primarily invests in junior opportunities where it can have the greatest impact through support mechanisms. From resource investments through to the disruptive technologies that are at the forefront of innovation, ThreeD aims to be positioned at the earliest possible stage and work with the investee’s management to launch concepts from design to reality.
- Locate unique and undervalued opportunities in mining, oil & gas, and technology.
- Evaluate the fundamentals of a company and its business plan, as well as the abilities of it’s management.
- Select the best investment that can benefit from the expertise and track record of ThreeD Advisory Services.
- Invest principal capital and more crucially, our time.
- Devise an exit strategy designed to maximize our relative return in light of changing fundamentals and opportunities
ThreeD’s investment strategy is to invest in multiple private and public companies across a variety of sectors primarily in North America. We seek to invest in early stage, promising companies where we may be the lead investor and can additionally provide investees with advisory services, mentoring and access to our network in order to earn increases to our equity stake.
NATURE OF PORTFOLIO HOLDINGS AND ASSOCIATED RISKS
The nature of our portfolio holdings is a combination of high tech and resource companies. Though they are primarily early stage companies, and therefore may have significant risk but at the same time, they have the ability to grow quickly and outperform. The resource components of our portfolio are primarily brown fields projects with the ability to be commercialized within 2-3 years.
As developing companies, our holdings are susceptible to risks related to execution, growth and other typical risk factors. However, we do, and from time to time, take an active role in the business of our investees through the provision of strategic advice, board representation and/or other means, that helps reduce our investment risks.
HOW WE MONITOR AND EVALUATE OUR PORTFOLIO
We take a very active role in our investees, ranging from board seats to advisory services, mentoring and networking, allowing us to monitor and evaluate them on a very consistent basis. Each company has very clearly articulated goals and milestones they are expected to achieve. Their rate of success or failure at achieving these milestones plays a significant role in evaluating our continued involvement with them.
THE TYPICAL LENGTH OF EACH INVESTMENT
We anticipate an investment period in each new company between 2-5 years. However, given the rapid growth nature of our high tech and bio tech investments, we acknowledge the fact that some may achieve liquidity events or successful exits much faster.